I’m growing increasingly concerned as to my ability to continue building my career as a physician-scientist in the US.
Uncertain and bleak times.
I’m growing increasingly concerned as to my ability to continue building my career as a physician-scientist in the US.
Uncertain and bleak times.
#sundaycooking
#sundaycooking
Details: bit.ly/4jWtGLs
Details: bit.ly/4jWtGLs
See our updated story on the Friday night news and its aftermath. scim.ag/4hTJQ6v
#poetrysunday
#poetrysunday
“The sample size was determined on how much money we could spend”
#AcademicChatter
“The sample size was determined on how much money we could spend”
#AcademicChatter
Proud to be part of the family ❤️
Proud to be part of the family ❤️
"The result, shown in the figure, is sweet and fruity, may be chilled if desired, and is best enjoyed with a hematologist." 😆
ashpublications.org/blood/articl...
"The result, shown in the figure, is sweet and fruity, may be chilled if desired, and is best enjoyed with a hematologist." 😆
ashpublications.org/blood/articl...
Happy 2025!
Happy 2025!
🎄🎅🤶
🎄🎅🤶
We've got the basic scrollytelling tech worked out and now need to choose a design.
We're not designers and would like to simply buy an HTML5 template if only for the colors and fonts.
We've got the basic scrollytelling tech worked out and now need to choose a design.
We're not designers and would like to simply buy an HTML5 template if only for the colors and fonts.
Multiomic analyses of CD22 CAR-associated IEC-HS identifying STAT2 upregulation, involved in type I and type II IFN signaling
Ruxolitinib to the rescue? 🤔
#ASH24
Multiomic analyses of CD22 CAR-associated IEC-HS identifying STAT2 upregulation, involved in type I and type II IFN signaling
Ruxolitinib to the rescue? 🤔
#ASH24
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Learn more in this week's issue: scim.ag/49nfztS
Register: bit.ly/ASH-a-Palooza
#ASHTrainee #HemeSky #Hematology #Fellow #MedSky #HemeOnc